The requirement of lipids for the formation of immunostimulating complexes (iscoms)

The iscom--immunostimulating complex--is a highly immunogenic formulation of microbial membrane antigens. The biochemically analyzed components of the iscom are the protein and the glycoside Quil A. Continued analysis of the iscom showed that the protein moiety--the antigen--does not contribute to the iscom as a construct. Instead, cholesterol and Quil A are the essential structural components assembled together into a typical cage-like structure. A more "fluid" lipid, such as phosphatidylcholine, is needed to facilitate the incorporation of amphipathic poly- or oligopeptides into the iscom matrix.     

Impaired immunogenicity of immunostimulating complexes (iscoms) by administration in slow-release formulations

This study was performed to explore the possible benefits of formulations and administration regimens that allow a protracted release of iscoms from the injection site. Three forms of slow release of immunostimulating complexes (iscoms) were therefore tested; encapsulation in sodium alginate gel, emulsification in Freund's incomplete adjuvant (FIA) or pulsed-release mimicked by weekly administrations. The administration of iscoms in a depot (alginate or FIA) or in pulses resulted in an antibody response of similar magnitude to that of a traditional two-dose scheme. The character of the immune response was on the other hand affected, i.e. the proportion of specific IgG2a and the IFN-gamma production was decreased by a protracted or repeated release of iscoms, either by a depot or by weekly administrations.     

Interactions between immune-stimulating complexes (ISCOMs) and peritoneal mononuclear leucocytes.

Studies were undertaken in mice using immune-stimulating complexes (ISCOMs) or micelles prepared from envelope glycoproteins of human influenza virus (PR8) and matrix (i.e., ISCOM skeleton without incorporated antigen). Electron microscopic studies showed that ISCOMs, in contrast to micelles, have a remarkable affinity for cell membranes and seem to rapidly promote their own internalization by cells to which they adhere. PR8 ISCOMs, but not matrix nor micelles, significantly increased the expression of membrane Ia by peritoneal mononuclear leucocytes 24 hr after intraperitoneal immunization.     

Synthesis and structure of chloro(ligand)bis(diphenylglyoximato)cobalt(III) complexes

The synthesis and characterization of trans-chloro- (ligand)bis(diphenylglyoximato)cobalt(III) complexes [ligand = pyridine (py), α-, β-, or γ-picoline (α-pic, β-pic, γ-pic), 3,5-lutidine (lut), p-toluidine (p-tol) and PPh₃] is presented. X-ray crystal structure determination of the pyridine (1) and p-toluidine (6) derivatives has been carried out. Compound 1 crystallizes in the monoclinic system, space group P2₁/n, with Z = 4 and unit cell parameters a = 23.124(4), b = 13.009(3) and c = 11.204(3) Å, and β= 93.14(2)°. Compound 6 crystallizes in the monoclinic system, space group P2₁/n, with Z = 4 and unit cell parameters a = 18.792(3), b = 12.540(2) and c = 15.346(3) Å, and β = 97.54(2)°.     

Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrix

In the iscom, antigen is attached by hydrophobic interactions to a matrix which is built up by the adjuvant Quil A and lipids. Thus, the iscom presents antigen in multiple copies on a small particle with a built-in adjuvant. By studying the specific antibody response, in vitro proliferation and IL-2 secretion by splenocytes from mice following different in vivo treatments with iscoms and/or matrix, we attempted to distinguish between nonspecific stimulatory effects, caused by the matrix or iscoms, and specific responses to the antigens incorporated into iscoms. The results strongly suggest that matrix and also iscoms exert a nonspecific adjuvant activity by a transient high spontaneous proliferation of cells collected within 2 weeks after administration of iscoms or matrix. This high rate of proliferation was preceded by suppressed proliferation, 3 days after injection with matrix or iscom. The adjuvant component included in iscoms, i.e., the matrix, does not excert a mitogenic stimulation in vitro or influence the levels of specific antibodies in serum. Specific responses to the antigens included in iscoms were recorded both as increasing levels of serum antibodies and as iscom-induced proliferation of immune spleen cells in vitro. The recruitment of IL-2 was only related to the specific stimulation induced by the antigens in iscom.     

Synthesis and structure of cyclic hexanuclear oxo-alkoxo-carboxylatoniobium(IV) complexes

The synthesis and crystal structure of novel oxo-alkoxo-carboxylato Nb(IV) complexes, Nb₆(μ₂-O)₃(μ₂-O₂CCX₃)₆(μ₂-OC₂H₅)₆(OC₂H₅)₆ (X=Cl, F) are described. The single-crystal X-ray structure determination carried out, revealed a closed ring of six Nb(IV) ions linked alternately by two carboxylato groups and an oxo group, and two ethoxo groups. The hexanuclear molecule can essentially be described as a trimer of Nb₂(μ₂-OC₂H₅)₂(OC₂H₅)₂, each linked by an μ₂-oxo group and two μ₂-carboxylato groups. The ethoxo-bridged Nb-Nb distances are 2.735(5) Å, which is consistent with a single metal-metal bond, while the oxo- and carboxylato-bridged non-bonding Nb-Nb distances are 3.635(2) Å.     

Synthesis and structure of heteroleptic ytterbium (II) tetrahydroborate complexes

The synthesis and characterization of (Tp^tBu,Me)Yb(BH₄)(THF)_n (n = 0, 3; n = 1, 4) complexes are reported. The compounds represent rare examples of lanthanide (II) tetrahydroborate complexes. The X-ray crystal structure of complex 4 has been determined and it shows a monomeric, formally seven coordinate ytterbium center, bearing one κ³ bonded Tp^tBu,Me ligand, a tetrahydroborate ligand and a coordinated THF molecule. The tetrahydroborate ligand binds in a κ³ fashion, via three bridging hydrogen atoms. IR spectroscopy data are consistent with the solid-state structure and the corresponding BD₄ analog of 4 shows the expected IR isotope shifts. The ¹H NMR spectra of 3 and 4 shows one set of resonances each for the BH₄ and the pyrazolylborate ligands indicating dynamic solution behavior. For complex 3, although X-ray quality crystals could not be obtained, the IR and NMR data are consistent with its formulation as the solvent-free analog of complex 4 with κ³-bonded BH₄ ligand.     

On the determination of empirical absolute chiral structure: chiroptical spectrum correlations for D3 lanthanide (III) complexes

Circularly polarized luminescence (CPL) from selected transitions of Eu(III) in resolved single crystals of Na3[Eu(ODA)3].2NaClO4.6H2O are compared to CPL results obtained from solutions containing perturbed racemic mixtures of Eu(2,6-pyridine-dicarboxylate)3 (3-) and enantiomerically pure d-f helicate LambdaLambda-(-)EuCr(L8)3] in order to determine an empirical relationship between helicity and CPL spectra. Comparison of the CPL results, even for the magnetic dipole allowed transitions of Eu(III) where one measures large chiral discrimination, shows that the signs and magnitudes do not correlate with the overall helicity of the Eu(III) site. It is concluded that the symmetry of the Eu(III) site in LambdaLambda-(-)EuCr(L8)3 is not close enough to D3 to allow for the confirmation of the presumed spectra:structure correlation.     

Factors affecting the structure of substituted tris(pyrazolyl)borate rhodium dicarbonyl complexes

Predictions by density functional calculations of the structure and relative energy of various isomers of the hydridotris(pyrazol-1-yl)borate ligand in Tp^3R,5R rhodium(I) dicarbonyl complexes (R=H, Me) and their IR and ¹¹B NMR spectra are compared to experimental observations. The lowest energy structure of Tp^3,5-Me-, Tp^3-Me-, and TpRh(CO)₂ is a non-classical square pyramidal (SPy) structure with a long metal apical ligand distance in rapid exchange with an equivalent SPy structure through a low energy trigonal bipyramid (TBP) transition state (a ‘reverse’ Berry pseudorotation). A second higher energy minimum, a pseudo square-planar complex with the third uncoordinated pyrazolyl arm rotated approximately parallel with the metal ligand pseudo-plane (SP1), is accessed through a second low energy transition state. Another pseudo square-planar minimum structure (SP2) is produced by a transition state, which lengthens the rhodium-apical nitrogen (of the third pyrazolyl arm) bond distance. The relative stability of SP2 depends on the degree of tris(pyrazolyl)borate (Tp) substitution, where 5-substituents larger than hydrogen disfavor SP2 because of steric interactions. The previously reported empirical correlation between ¹¹B NMR chemical shifts, ν_BH stretching frequencies, and the crystallographic Tp ligand denticity is reproduced by our calculations. The variety of structures observed by experiment can be explained by the calculated relative energies of the structures, the bulk dielectric of the solvents when in solution, specific interaction by certain solvents, and conditions of crystallization when in the solid-state.     

New homoleptic tris(diphosphanylamido) complexes of the lanthanides - synthesis and structure

New homoleptic diphosphanylamido compounds of the lanthanides, [Ln{N(PPh₂)₂}₃] (Ln = Sm, Gd, Dy), were synthesized and characterized by single crystal X-ray diffraction in the solid state and partly by NMR in solution. In the solid state the complexes solely show a η²-coordination of the {(Ph₂P)₂N}⁻ ligand. The dependence of the Ln-N and the Ln-P bond distance on the ion radius of the center metal was investigated.     

Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein.

The importance of each of the two surface glycoproteins of measles virus in active and passive immunization was examined in mice. Infected-cell lysates were depleted of either the hemagglutinin (H) or fusion (F) glycoprotein by using multiple cycles of immunoaffinity chromatography. The products were used to prepare immune-stimulating complexes (iscoms) containing either F or H glycoprotein. Such complexes are highly immunogenic, possibly as a result of effective presentation of viral proteins to the immune system [B. Morein, B. Sundquist, S. H?glund, K. Dalsgaard, and A. Osterhaus, Nature (London) 308:457-460, 1984]. Groups of 3-week-old BALB/c mice were inoculated with the iscom preparations. All animals developed hemolysis-inhibiting antibodies, whereas only sera of animals immunized with the iscoms containing the H glycoprotein had hemagglutination-inhibiting antibodies. Sera from animals immunized with the H or F preparation only precipitated the homologous glycoprotein in radioimmune precipitation assays. The immunized animals were challenged with a lethal dose of the hamster neurotropic variant of measles virus. Of the 7-week-old animals in the nonimmunized control group, 50% died within 10 days after challenge. No animals in the immunized groups showed symptoms of disease throughout the observation period of 3 months. Passive administration of anti-H monoclonal antibodies gave full protection against the 100% lethal acute infection with the hamster neurotropic variant of measles virus in newborn mice, whereas anti-F monoclonal antibodies failed to protect the animals. This study emphasizes that both H and F glycoproteins need to be considered in the development of measles virus subunit vaccines.     

Effect of pyrazole-substitution on the structure and nuclearity of Cu(II)-pyrazolato complexes

Trinuclear Cu(II)-pyrazolates of the general formula (Bu₄N)₂[Cu₃(μ₃-Cl)₂(μ-4-R-pz)₃Cl₃] (pz=pyrazolato anion, R=Cl, Br, I, Me), 1-4, have been prepared and characterized by X-ray diffraction and/or ¹H NMR, IR, UV-Vis spectroscopy and elemental analysis. Their structure and spectroscopic properties match the ones of the parent unsubstituted complex (Bu₄N)₂[Cu₃(μ₃-Cl)₂(μ-pz)₃Cl₃], indicating that 4-substitution of the pyrazole ligands with halogen or methyl groups does not induce structural variation. In contrast, dinuclear complexes (Bu₄N)₄[Cu₂(μ-3-Me-pz)₂Cl₄]Cl₂ · 4H₂O, Cu₂(μ-Cl)(μ-3,5-Me₂-pz)(3,5-Me₂-pzH)₄Cl₂, Cu₂(μ-Cl)(μ-OH)(3-Me-5-Ph-pzH)₄Cl₂ · 3-Me-5-Ph-pzH and Cu₂(μ-Cl)₂(3,5-Ph₂-pzH)₄Cl₂, 5-8, have been prepared with 3- and 3,5-substituted pyrazoles by the same or similar synthetic protocols.     

Formation and structure of Cu(II)-poly(L-lysine) complexes in aqueous solution.

Cu(II)-poly(L-lysine) complexes have been studied using potentiometric titrations, optical absorption and circular dichroism spectra. As in the Cu(II)-poly(L-arginine) system studied previously potentiometric and spectral data consistently show that two types of complexes are formed. The first formed below pH 7.6 contains two amine nitrogens and two oxygen from water molecules at the corners of a square in which the metal occupies the center. The second is obtained at pH above 7.6 when the oxygen atoms are replaced by two adjacent peptide nitrogens.     

Preparation, structure and decomposition of gold(I) and gold(III) acetylide complexes

1-Alkynyl-dimethyl(triorganophosphine)gold(III) complexes of the type cis-Me₂(Ph₃P)Au-CC-R with R = H, Me, Ph (1-3) have been prepared from the cis-Me₂(Ph₃P)AuX (X = Cl, I) complexes and lithium alkynyls. The crystal structures of 1 and 2 have been determined together with those of the reference compounds cis-Me₂(Ph₃P)AuX (X = Cl, I) and cis-Me₂(Me₃P)AuI. The molecules have a standard square planar geometry and are not associated into oligomers. Due to the different hybridization of the carbon orbitals, the Au-C(CR) bonds are found significantly shorter than the Au-CH₃ bonds. Compounds 1-3 are stable colourless, crystalline solids at 20 °C but decompose on heating with selective (cis) reductive elimination of ethane and formation of the gold(I) alkynyls (Ph₃P)Au-CC-R thus retaining the stronger gold-alkynyl bonds. Two complexes of this type have also been prepared by conventional routes from (R₃P)AuX complexes and the crystal structures of (Me₃P)Au-CC-Ph and [(p-Tol)₃P]Au-CC-H have been determined. The former with the small Me₃P ligand is associated into two different trimers via aurophilic bonding and further aggregated into chains via weak inter-trimer contacts, while the latter is a monomer owing to the steric bulk of the (p-Tol)₃P ligand.     

Synthesis and the structure of mixed carboxylatoplatinum(IV) complexes involving one trifluoroacetate ligand

Mono(trifluoroacetato)platinum(IV) complexes of the formula [Pt^IV(dach)L₃(TFAc)] (dach = trans-(±)-1,2-diaminocyclohexane, TFAc = trifluoroacetate, L = acetate or propionate) could be prepared from the reaction of [Pt^IV(dach)L₃(OH)] with trifluoroacetic anhydride in the presence of a base and the crystal structure of compound 4 was determined by X-ray crystallography. In vitro antitumor activity of complex 4 (ED₅₀ = 3.1 μM) was found to be much higher than carboplatin (ED₅₀ = 10.2 μM).     

Self-assembled monolayers of bis(salicylaldiminato)nickel(II) Schiff-base complexes: synthesis and structure

The synthesis of two derivatized Ni^II Schiff-base complexes is reported. Self-assembled monolayers (SAMs) have been obtained by reaction of coupling layers, functionalized glass substrates and the derivatized complex precursors. The self-assembled films have been characterized by contact angle measurements, X-ray photoelectron spectroscopy, and UV-Vis absorption spectroscopy. A structure of these SAMs is proposed on the basis of spectroscopic data and molecular metrical parameters.